InnoCare Pharma Limited (HKG:9969)
Hong Kong · Delayed Price · Currency is HKD 12.66
+0.06 (0.48%)
Feb 13, 2026, 4:08 PM HKT
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 25.4 billion as of February 13, 2026. Its market cap has increased by 118.82% in one year.
Market Cap
25.40B
Enterprise Value
19.56B
Revenue
1.56B
Ranking
n/a
PE Ratio
n/a
Stock Price
12.66
Market Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 12.28B to 25.40B, an increase of 106.85%. That is a compound annual growth rate of 13.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 25.40B | 7.22% |
| Dec 31, 2025 | 23.69B | 93.83% |
| Dec 31, 2024 | 12.22B | -6.80% |
| Dec 29, 2023 | 13.11B | -44.09% |
| Dec 30, 2022 | 23.45B | 11.18% |
| Dec 31, 2021 | 21.09B | 21.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Henlius Biotech | 39.10B |
| Shanghai Junshi Biosciences | 35.93B |
| Biocytogen Pharmaceuticals (Beijing) | 34.88B |
| Duality Biotherapeutics | 30.54B |
| TransThera Sciences (Nanjing) | 27.89B |
| Genscript Biotech | 27.05B |
| PegBio | 26.11B |
| Ascletis Pharma | 17.87B |